HOLA® - Hysteroscopic Outpatient Laser Applications
HOLA® is an acronym and stands for "Hysteroscopic Outpatient Laser Applications". HOLA® covers all applications in hysteroscopy:
Worldwide, approximately one third of women above the age of 30 are affected by myomas. biolitec® offers a laser therapy that has significantly fewer complications and side effects than previous treatment methods. Hysterectomy as a standard method does not only carry with it the loss of the ability to bear children and a sometimes heavy psychological burden, but can also lead to the early onset of menopause. The minimally invasive treatment of myomas which maintains the uterus is therefore not only of great importance for women who want to have children.
The benefits of HOLA® are: The laser energy used avoids constricting the muscle tissue and can be used either with or without minimal local anaesthetic. The enucleation with the laser fiber in contact mode leads to precise control of the laser energy and therefore a controlled cut. The coagulation that occurs in parallel ensures that the work is done without haemorrhaging. Continuous cleaning during the entire operation allows for the safe use of laser energy with constantly good visibility.
|16.11.-19.11.2020||Medica 2020, Hall 10 Booth H46 |
in Dusseldorf, Germany
Postponed to 08.05.-11.05. 2021
|Endometriosis 2020 |
in Rome, Italy
Laser Safety Course biolitec
Postponed from 05.12.-08.12.2020
|Endometriosis 2021 |
in Rome, Italy